These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16649096)

  • 1. Multiple sclerosis in Jordan: A clinical and epidemiological study.
    El-Salem K; Al-Shimmery E; Horany K; Al-Refai A; Al-Hayk K; Khader Y
    J Neurol; 2006 Sep; 253(9):1210-6. PubMed ID: 16649096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sclerosis in Iraq: does it have the same features encountered in Western countries?
    Al-Araji A; Mohammed AI
    J Neurol Sci; 2005 Jul; 234(1-2):67-71. PubMed ID: 15946690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and disability progression in multiple sclerosis in Tunisia: do we really have a more aggressive disease course?
    Sidhom Y; Damak M; Riahi A; Hizem Y; Mrissa R; Mhiri C; Gouider R
    J Neurol Sci; 2014 Aug; 343(1-2):110-4. PubMed ID: 24980939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the natural history and prognostic features of early onset and adult onset multiple sclerosis in Jordanian population.
    El-Salem K; Khader Y
    Clin Neurol Neurosurg; 2007 Jan; 109(1):32-7. PubMed ID: 16870328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of multiple sclerosis in the north-west Italian province of Genoa.
    Solaro C; Allemani C; Messmer Uccelli M; Canevari E; Dagnino N; Pizio R; Regesta G; Tanganelli P; Battaglia MA; Mancardi GL
    J Neurol; 2005 Apr; 252(4):436-40. PubMed ID: 15726261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological study of multiple sclerosis in La Rioja.
    Bártulos Iglesias M; Marzo Sola ME; Estrella Ruiz LA; Bravo Anguiano Y
    Neurologia; 2015; 30(9):552-60. PubMed ID: 24975346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostics factors of renal failure in multiple sclerosis].
    Viart L; Elalouf V; Petit J; Al Khedr A; Kristkowiak P; Saint F
    Prog Urol; 2012 Dec; 22(16):1026-32. PubMed ID: 23178100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of multiple sclerosis in Asahikawa, a city in northern Japan.
    Itoh T; Aizawa H; Hashimoto K; Yoshida K; Kimura T; Katayama T; Koyama S; Yahara O; Kikuchi K
    J Neurol Sci; 2003 Oct; 214(1-2):7-9. PubMed ID: 12972381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric Multiple Sclerosis in Rio de Janeiro: Secondary Progression and Disability.
    Cerqueira Pinto SC; Ferreira Vasconcelos CC; Aurenção JCK; Alvarenga MP; das Graças Gomes Camargo SM; Santos Thuler LC; Alvarenga RP
    Pediatr Neurol; 2019 May; 94():48-54. PubMed ID: 30850228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study.
    D'Amico E; Patti F; Zanghì A; Chisari CG; Lo Fermo S; Zappia M
    Eur J Neurol; 2018 Dec; 25(12):1425-1431. PubMed ID: 29956427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is late-onset multiple sclerosis associated with a worse outcome?
    Tremlett H; Devonshire V
    Neurology; 2006 Sep; 67(6):954-9. PubMed ID: 17000960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary progressive multiple sclerosis - clinical course and potential predictive factors.
    Pokryszko-Dragan A; Gruszka E; Bilińska M; Dubik-Jezierzańska M
    Neurol Neurochir Pol; 2008; 42(1):6-11. PubMed ID: 18365957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and long term prognosis in early onset multiple sclerosis.
    Deryck O; Ketelaer P; Dubois B
    J Neurol; 2006 Jun; 253(6):720-3. PubMed ID: 16502213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A CLINICO-EPIDEMIOLOGICAL STUDY OF MULTIPLE SCLEROSIS IN MOSUL CITY, IRAQ.
    Taher Y; Ahmed M; Majdal H
    Georgian Med News; 2023; (340-341):47-52. PubMed ID: 37805872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disability profile of MS did not change over 10 years in a population-based prevalence cohort.
    Pittock SJ; Mayr WT; McClelland RL; Jorgensen NW; Weigand SD; Noseworthy JH; Rodriguez M
    Neurology; 2004 Feb; 62(4):601-6. PubMed ID: 14981177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of patients with multiple sclerosis enrolled in a new registry in Egypt.
    Zakaria M; Zamzam DA; Abdel Hafeez MA; Swelam MS; Khater SS; Fahmy MF; Abdel Hady A; Fouad MM; Abdel Nasser A; Aref H; Gadallah M
    Mult Scler Relat Disord; 2016 Nov; 10():30-35. PubMed ID: 27919495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric Multiple Sclerosis Severity Score in a large US cohort.
    Santoro JD; Waltz M; Aaen G; Belman A; Benson L; Gorman M; Goyal MS; Graves JS; Harris Y; Krupp L; Lotze T; Mar S; Moodley M; Ness J; Rensel M; Rodriguez M; Schreiner T; Tillema JM; Waubant E; Weinstock-Guttman B; Hurtubise BF; Roalstad S; Rose J; Casper TC; Chitnis T;
    Neurology; 2020 Sep; 95(13):e1844-e1853. PubMed ID: 32690790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis in Isfahan, Iran.
    Saadatnia M; Etemadifar M; Maghzi AH
    Int Rev Neurobiol; 2007; 79():357-75. PubMed ID: 17531850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study of multiple sclerosis with early onset.
    Ghezzi A; Pozzilli C; Liguori M; Marrosu MG; Milani N; Milanese C; Simone I; Zaffaroni M
    Mult Scler; 2002 Apr; 8(2):115-8. PubMed ID: 11990867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Older Age at Multiple Sclerosis Onset Is an Independent Factor of Poor Prognosis: A Population-Based Cohort Study.
    Guillemin F; Baumann C; Epstein J; Kerschen P; Garot T; Mathey G; Debouverie M;
    Neuroepidemiology; 2017; 48(3-4):179-187. PubMed ID: 28793296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.